GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » Total Assets

Double Bond Pharmaceutical International AB (XSAT:DBP B) Total Assets : kr11.76 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB Total Assets?

Double Bond Pharmaceutical International AB's Total Assets for the quarter that ended in Mar. 2025 was kr11.76 Mil.

During the past 12 months, Double Bond Pharmaceutical International AB's average Total Assets Growth Rate was 23.40% per year. During the past 3 years, the average Total Assets Growth Rate was -18.00% per year. During the past 5 years, the average Total Assets Growth Rate was 12.60% per year.

During the past 10 years, Double Bond Pharmaceutical International AB's highest 3-Year average Total Assets Growth Rate was 117.70%. The lowest was -37.30%. And the median was 1.50%.

Total Assets is connected with ROA %. Double Bond Pharmaceutical International AB's annualized ROA % for the quarter that ended in Mar. 2025 was -36.59%. Total Assets is also linked to Revenue through Asset Turnover. Double Bond Pharmaceutical International AB's Asset Turnover for the quarter that ended in Mar. 2025 was 0.00.


Double Bond Pharmaceutical International AB Total Assets Historical Data

The historical data trend for Double Bond Pharmaceutical International AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Bond Pharmaceutical International AB Total Assets Chart

Double Bond Pharmaceutical International AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.78 27.80 15.39 11.60 12.35

Double Bond Pharmaceutical International AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.97 7.13 6.72 12.35 11.76

Double Bond Pharmaceutical International AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Double Bond Pharmaceutical International AB's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=4.001+8.35
=12.35

Double Bond Pharmaceutical International AB's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=2.898+8.865
=11.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) Total Assets Explanation

Total Assets is connected with ROA %.

Double Bond Pharmaceutical International AB's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=-4.412/( (12.35+11.763)/ 2 )
=-4.412/12.0565
=-36.59 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Double Bond Pharmaceutical International AB's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=0/( (12.35+11.763)/ 2 )
=0/12.0565
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Double Bond Pharmaceutical International AB Total Assets Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Double Bond Pharmaceutical International AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines